Renovaro Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RENB Nasdaq 8731 https://renovarobio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Renovaro Inc

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership - Apr 24th, 2024 1:00 pm
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care - Apr 18th, 2024 12:45 pm
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace - Feb 15th, 2024 2:25 pm
Statement of Renovaro Inc - Feb 14th, 2024 3:01 pm
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine - Feb 13th, 2024 2:31 pm
Renovaro Biosciences Announces Results of Special Meeting of Shareholders - Jan 25th, 2024 5:45 pm
Renovaro BioSciences Releases CEO Shareholder Message - Jan 18th, 2024 2:30 pm
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD - Jan 16th, 2024 1:00 pm
Renovaro BioSciences CEO Featured in Recent Proactive Interview - Nov 28th, 2023 1:30 pm
Renovaro BioSciences Poised to Spearhead Advancements in Battle Against Diseases - Nov 23rd, 2023 2:30 pm
Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024 - Nov 22nd, 2023 3:44 pm
Renovaro BioSciences Eyes Opportunity in Precision Medicine Market - Nov 21st, 2023 1:30 pm
Renovaro Biosciences CEO Provides Update on Combination with GEDiCube - Nov 14th, 2023 2:00 pm
Renovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics - Nov 10th, 2023 1:30 pm
Renovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced - Nov 7th, 2023 1:30 pm
Renovaro BioSciences CEO Provides Insights on Agreement to Combine with GEDi Cube - Oct 24th, 2023 1:00 pm
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors - Oct 11th, 2023 1:25 pm
Renovaro BioSciences Announces Board Appointments of Two Finance Experts - Oct 11th, 2023 12:30 pm
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors - Oct 10th, 2023 12:00 pm
Renovaro BioSciences CEO Releases Shareholder Letter - Oct 4th, 2023 1:00 pm